MRK Stock Merck & Company Inc - Complete Overview

Nyse / Pharmaceutical Products / Healthcare / MRK Stock

Merck & Company Inc (MRK) price per share as of 20 Apr 2018
USD
Your sentiment
COLDTRENDOMETERHOT
Shares Outstanding 2.7B
Avg Daily Volume 12.28M
Market Cap 147.54B
Volatility 19.22% LOW

MERCK & COMPANY INC (MRK) OVERVIEW

MRK stock is a pharmaceutical products company traded on Nyse. It is valued at 147.54B US dollars. There are 2.7B shares outstanding which Merck & Company Inc issued to investors. Volatility of the stock is LOW, and the daily volume is 19.22% stock on average. Merck & Company Inc is paying dividends with the latest yield of 3.50%. It brought investors a total return of -0.73% over the last 12 months. Merck & Company Inc stock is relatively expensive. It's P/E ratio is above the market average.

Merck & Company Inc (MRK) STOCK PRICE PERFORMANCE

MRK SHAREHOLDER'S RETURN

Earnings Per Share 0.88
Dividends Per Share 1.89
12 Months Price Performance Negative
Dividend Yield Low
Total Return Negative

MRK LATEST NEWS

Does Dicerna's Settlement Agreement With Alnylam Make It A Buy?

Dicerna settles a dispute between it and Alnylam over trade secrets. The settlement will allow Dicerna to continue its operations as planned with a total of $25 million given to Alnylam in cash and st

I'm Buying Bristol-Myers Down Near 52-Week Lows

In 2016 I placed a very large bet on BMY.I unwound that trade in late 2017/early 2018, locking in solid profits.Well, recent weakness has inspired me to begin loading back up on BMY; I just used the p

Dynavax: Positive Results, Market Confusion

This week, Dynavax released two major updates on trials for cancer immuno-therapy drug, SD-101.Preliminary data from a Phase 1b/2 study of head-and-neck cancer and a duration study from a previous mel

Merck Posts Another Advance In The Lucrative Lung Cancer Market

Merck presents positive first-line NSCLC results at the AACR Annual Meeting 2018 conference.Keytruda in combination with chemo was able to reduce the rate of disease progression or death by 51% compar

What Happened in the Stock Market Today

On a day stocks staged a broad-based rally, Merck and Bristol-Myers Squibb reported drug trial results that sent their shares in opposite directions.

With Lackluster Growth, Merck's Shareholders Need To Act Now

Merck's shares are too expensive relative to its full potential.KEYTRUDA continues to deliver strong results.Its dividend is not meaningful enough to reward shareholders.

Merck & Company Inc (MRK) TECHNICAL INDICATORS

Name Value Action
RSI(14) 65.41 Strong buy
CMO(14) 30.82 Strong buy
ADX(14) 22.39 Buy
Williams %R -15.85 Sell

MRK STOCK VALUATION

MRK Industry Sector Market
Price to Earnings 62.18 67.64 84.09 30.67
Price to Book Value 4.30 3.93 4.63 3.52
Price to Sales 3.68 3.57 4.30 3.34
Return on Equity 6.30% 16.58% 22.79% 15.18%
Return on Assets 2.60% 4.83% 6.75% 5.64%
All values TTM (trailing twelve months). Source: Quandl.com

MRK FORUM DISCUSSIONS